US Stock MarketDetailed Quotes

ATXS Astria Therapeutics Inc

Watchlist
  • 11.140
  • +0.020+0.18%
Close Sep 27 16:00 ET
  • 11.140
  • 0.0000.00%
Post 20:01 ET
628.58MMarket Cap-4680P/E (TTM)

Astria Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-56.98%-16.79M
-44.07%-19.09M
-57.23%-68.45M
-183.55%-30.24M
-39.12%-14.26M
-6.31%-10.7M
-5.53%-13.25M
-44.38%-43.53M
-69.65%-10.66M
-32.26%-10.25M
Net income from continuing operations
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.69%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
-52.42%-12M
Operating gains losses
----
----
----
----
----
----
----
2,071.83%1.54M
--0
--0
Other non cash items
389.12%944K
-541.38%-512K
223.30%545K
128.65%163K
52.08%73K
22.15%193K
246.84%116K
-100.27%-442K
-198.44%-569K
860.00%48K
Change In working capital
1,171.53%5.49M
58.60%-1.41M
-191.16%-2.41M
-150.60%-1.06M
196.51%1.62M
608.24%432K
-3,796.74%-3.4M
168.27%2.65M
65.09%2.1M
142.64%545K
-Change in prepaid assets
112.71%1.41M
-7.64%-930K
-189.92%-4.55M
-193.45%-3.23M
-61.13%-1.12M
983.61%661K
-630.06%-864K
-1,944.71%-1.57M
-193.46%-1.1M
66.91%-692K
-Change in payables and accrued expense
5,508.97%4.22M
86.75%-317K
-24.66%2.74M
-12.02%2.33M
144.16%2.89M
40.00%-78K
-4,171.43%-2.39M
210.97%3.64M
290.69%2.65M
43.45%1.18M
-Change in other current liabilities
12.58%-132K
-11.03%-161K
-206.27%-610K
-128.91%-159K
-381.82%-155K
-843.75%-151K
-866.67%-145K
184.29%574K
--550K
--55K
Cash from discontinued investing activities
Operating cash flow
-56.98%-16.79M
-44.07%-19.09M
-57.23%-68.45M
-183.55%-30.24M
-39.12%-14.26M
-6.31%-10.7M
-5.53%-13.25M
-44.38%-43.53M
-69.65%-10.66M
-32.26%-10.25M
Investing cash flow
Cash flow from continuing investing activities
-17.58%-68.1M
-164.74%-126.23M
180.81%135.05M
98.51%-2.02M
-100.21%-4K
-751.76%-57.92M
819.55%194.99M
-1,231.17%-167.13M
-246.62%-135.18M
1.95M
Net PPE purchase and sale
---305K
--0
72.53%-25K
48.39%-16K
93.10%-4K
--0
---5K
-333.33%-91K
---31K
---58K
Net investment purchase and sale
-17.05%-67.8M
-164.73%-126.23M
180.87%135.08M
98.52%-2M
--0
-752.02%-57.92M
819.57%195M
-779.15%-167.04M
-246.54%-135.15M
--2.01M
Cash from discontinued investing activities
Investing cash flow
-17.58%-68.1M
-164.74%-126.23M
180.81%135.05M
98.51%-2.02M
-100.21%-4K
-751.76%-57.92M
819.55%194.99M
-1,231.17%-167.13M
-246.62%-135.18M
--1.95M
Financing cash flow
Cash flow from continuing financing activities
-65.57%94K
383,162.16%141.81M
-38.92%88.4M
-26.93%87.98M
-99.55%110K
273K
37K
38.78%144.72M
708,117.65%120.4M
405,300.00%24.32M
Net common stock issuance
--0
--137.17M
-39.17%87.98M
-26.90%87.98M
--0
--0
--0
38.73%144.64M
--120.35M
----
Proceeds from stock option exercised by employees
-65.57%94K
12,421.62%4.63M
400.00%420K
--0
223.53%110K
--273K
--37K
265.22%84K
194.12%50K
--34K
Cash from discontinued financing activities
Financing cash flow
-65.57%94K
383,162.16%141.81M
-38.92%88.4M
-26.93%87.98M
-99.55%110K
--273K
--37K
38.78%144.72M
708,117.65%120.4M
405,300.00%24.32M
Net cash flow
Beginning cash position
-14.96%172.18M
749.25%175.69M
-76.12%20.69M
160.04%119.97M
345.44%134.12M
331.04%202.46M
-76.12%20.69M
245.81%86.63M
-65.02%46.14M
-78.44%30.11M
Current changes in cash
-24.08%-84.8M
-101.94%-3.52M
335.07%155.01M
318.98%55.72M
-188.31%-14.15M
-305.33%-68.34M
558.36%181.78M
-207.09%-65.94M
43.79%-25.45M
306.96%16.03M
End cash Position
-34.85%87.38M
-14.96%172.18M
749.25%175.69M
749.25%175.69M
160.04%119.97M
345.44%134.12M
331.04%202.46M
-76.12%20.69M
-76.12%20.69M
-65.02%46.14M
Free cash flow
-59.84%-17.1M
-44.02%-19.09M
-56.95%-68.47M
-182.88%-30.25M
-38.37%-14.26M
-6.29%-10.7M
-5.57%-13.26M
-44.58%-43.62M
-70.14%-10.7M
-33.01%-10.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -56.98%-16.79M-44.07%-19.09M-57.23%-68.45M-183.55%-30.24M-39.12%-14.26M-6.31%-10.7M-5.53%-13.25M-44.38%-43.53M-69.65%-10.66M-32.26%-10.25M
Net income from continuing operations -92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.69%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M-52.42%-12M
Operating gains losses ----------------------------2,071.83%1.54M--0--0
Other non cash items 389.12%944K-541.38%-512K223.30%545K128.65%163K52.08%73K22.15%193K246.84%116K-100.27%-442K-198.44%-569K860.00%48K
Change In working capital 1,171.53%5.49M58.60%-1.41M-191.16%-2.41M-150.60%-1.06M196.51%1.62M608.24%432K-3,796.74%-3.4M168.27%2.65M65.09%2.1M142.64%545K
-Change in prepaid assets 112.71%1.41M-7.64%-930K-189.92%-4.55M-193.45%-3.23M-61.13%-1.12M983.61%661K-630.06%-864K-1,944.71%-1.57M-193.46%-1.1M66.91%-692K
-Change in payables and accrued expense 5,508.97%4.22M86.75%-317K-24.66%2.74M-12.02%2.33M144.16%2.89M40.00%-78K-4,171.43%-2.39M210.97%3.64M290.69%2.65M43.45%1.18M
-Change in other current liabilities 12.58%-132K-11.03%-161K-206.27%-610K-128.91%-159K-381.82%-155K-843.75%-151K-866.67%-145K184.29%574K--550K--55K
Cash from discontinued investing activities
Operating cash flow -56.98%-16.79M-44.07%-19.09M-57.23%-68.45M-183.55%-30.24M-39.12%-14.26M-6.31%-10.7M-5.53%-13.25M-44.38%-43.53M-69.65%-10.66M-32.26%-10.25M
Investing cash flow
Cash flow from continuing investing activities -17.58%-68.1M-164.74%-126.23M180.81%135.05M98.51%-2.02M-100.21%-4K-751.76%-57.92M819.55%194.99M-1,231.17%-167.13M-246.62%-135.18M1.95M
Net PPE purchase and sale ---305K--072.53%-25K48.39%-16K93.10%-4K--0---5K-333.33%-91K---31K---58K
Net investment purchase and sale -17.05%-67.8M-164.73%-126.23M180.87%135.08M98.52%-2M--0-752.02%-57.92M819.57%195M-779.15%-167.04M-246.54%-135.15M--2.01M
Cash from discontinued investing activities
Investing cash flow -17.58%-68.1M-164.74%-126.23M180.81%135.05M98.51%-2.02M-100.21%-4K-751.76%-57.92M819.55%194.99M-1,231.17%-167.13M-246.62%-135.18M--1.95M
Financing cash flow
Cash flow from continuing financing activities -65.57%94K383,162.16%141.81M-38.92%88.4M-26.93%87.98M-99.55%110K273K37K38.78%144.72M708,117.65%120.4M405,300.00%24.32M
Net common stock issuance --0--137.17M-39.17%87.98M-26.90%87.98M--0--0--038.73%144.64M--120.35M----
Proceeds from stock option exercised by employees -65.57%94K12,421.62%4.63M400.00%420K--0223.53%110K--273K--37K265.22%84K194.12%50K--34K
Cash from discontinued financing activities
Financing cash flow -65.57%94K383,162.16%141.81M-38.92%88.4M-26.93%87.98M-99.55%110K--273K--37K38.78%144.72M708,117.65%120.4M405,300.00%24.32M
Net cash flow
Beginning cash position -14.96%172.18M749.25%175.69M-76.12%20.69M160.04%119.97M345.44%134.12M331.04%202.46M-76.12%20.69M245.81%86.63M-65.02%46.14M-78.44%30.11M
Current changes in cash -24.08%-84.8M-101.94%-3.52M335.07%155.01M318.98%55.72M-188.31%-14.15M-305.33%-68.34M558.36%181.78M-207.09%-65.94M43.79%-25.45M306.96%16.03M
End cash Position -34.85%87.38M-14.96%172.18M749.25%175.69M749.25%175.69M160.04%119.97M345.44%134.12M331.04%202.46M-76.12%20.69M-76.12%20.69M-65.02%46.14M
Free cash flow -59.84%-17.1M-44.02%-19.09M-56.95%-68.47M-182.88%-30.25M-38.37%-14.26M-6.29%-10.7M-5.57%-13.26M-44.58%-43.62M-70.14%-10.7M-33.01%-10.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data